Cargando…
Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463815/ https://www.ncbi.nlm.nih.gov/pubmed/36085077 http://dx.doi.org/10.1186/s13045-022-01277-5 |
| _version_ | 1784787468334137344 |
|---|---|
| author | Mao, Jie Liu, Shujun Ai, Min Wang, Zhuo Wang, Duowei Li, Xianjing Hu, Kaiyong Gao, Xinghua Yang, Yong |
| author_facet | Mao, Jie Liu, Shujun Ai, Min Wang, Zhuo Wang, Duowei Li, Xianjing Hu, Kaiyong Gao, Xinghua Yang, Yong |
| author_sort | Mao, Jie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9463815 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94638152022-09-11 Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety Mao, Jie Liu, Shujun Ai, Min Wang, Zhuo Wang, Duowei Li, Xianjing Hu, Kaiyong Gao, Xinghua Yang, Yong J Hematol Oncol Correction BioMed Central 2022-09-09 /pmc/articles/PMC9463815/ /pubmed/36085077 http://dx.doi.org/10.1186/s13045-022-01277-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Mao, Jie Liu, Shujun Ai, Min Wang, Zhuo Wang, Duowei Li, Xianjing Hu, Kaiyong Gao, Xinghua Yang, Yong Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety |
| title | Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety |
| title_full | Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety |
| title_fullStr | Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety |
| title_full_unstemmed | Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety |
| title_short | Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety |
| title_sort | correction to: a novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463815/ https://www.ncbi.nlm.nih.gov/pubmed/36085077 http://dx.doi.org/10.1186/s13045-022-01277-5 |
| work_keys_str_mv | AT maojie correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety AT liushujun correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety AT aimin correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety AT wangzhuo correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety AT wangduowei correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety AT lixianjing correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety AT hukaiyong correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety AT gaoxinghua correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety AT yangyong correctiontoanovelmelittinnanoliposomeexertedexcellentantihepatocellularcarcinomaefficacywithbetterbiologicalsafety |